Replies to post #49282 on Cytodyn Inc (CYDY)

[Amatuer17]

Three announcements

1. Pre-clinical study results - they call it statistically significant inhibition of metastasis

2. Work on basket trial/master protocol to test L on multiple cancers. A good initiative - not sure when it will materialize and if they will have funds to actually start that

3. New combo therapy in cancer - CytoDyn has also recently been cleared by the FDA for a Phase 2 protocol to proceed for combination therapy of leronlimab and Regorafenib in patients with metastatic colorectal cancer (mCRC).
Again not sure who will drive this and has funds.

Compared to previous fluff this is good direction specially being in cancer space. Makes it attractive target as single drug becomes more attractive for multiple areas.